Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351351 · ClinicalTrials.gov registry record · NA
Trial Comparing Dual Probe Ultrasonic Lithotripsy to a Single Probe Ultrasonic Lithotripsy
A NA study of Kidney Stones, sponsored by Indiana Kidney Stone Institute.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 7
- Study locations
NCT00351351: Completed NA study of Kidney Stones, sponsored by Indiana Kidney Stone Institute.
NCT00351351 is a NA study of Kidney Stones that has completed, run by Indiana Kidney Stone Institute. The registered enrollment target is 70 participants, below the 290-participant average among 15 other Kidney Stones trials with a reported enrollment target (76% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00351351, a NA study of Kidney Stones, has completed, sponsored by Indiana Kidney Stone Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 7
- Study locations
Study Summary
Percutaneous nephrolithotomy (PNL), in conjunction with intracorporeal lithotripsy, allows for the rapid removal of any kidney stone regardless of size. Currently, the choice of intracorporeal lithotripters includes ultrasonic, pneumatic, and combined ultrasonic/pneumatic energy sources. Recently, a novel dual probe design as been introduced by Cybersonics of Erie, Pennsylvania. This dual probe intracorporeal lithotrite is called the Cyberwand, and is composed of a fixed inner probe vibrating at an ultrasonic frequency with an outer probe vibrating at about 1,000 Hz. As this new design has the potential to revolutionize intracorporeal lithotripsy, we intend to compare this novel technology to currently available lithotripsy technology in a randomized clinical trial.
Primary Outcome
stone clearance rate calculated in mm\^2/min per protocol specification
Conditions Studied
Interventions
- DEVICE Cyberwand
- DEVICE single probe ultrasonic
Study Locations (7)
Illinois
- Northwestern University Dept. of Urology - Chicago
Indiana
- Methodist Hospital - Indianapolis
Maryland
- John's Hopkins University - Baltimore
North Carolina
- Duke University - Durham
Wisconsin
- University of Wisconsin - Madison
British Columbia
- Vancouver Hospital - Vancouver
Ontario
- University of Western Ontario - St. Joseph's Hospital - London
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-05 |
| Phase | NA |
What the finished NCT00351351 record still lists
NCT00351351 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 290-participant average among 15 other Kidney Stones trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Kidney Stones appearing as the primary indexed condition, and to 2 interventions - of which Cyberwand is the first listed.
NCT00351351 lists 7 locations in 7 states (Illinois, Indiana, Maryland).
Frequently Asked Questions
What is clinical trial NCT00351351 about?
NCT00351351 is a clinical study titled "Trial Comparing Dual Probe Ultrasonic Lithotripsy to a Single Probe Ultrasonic Lithotripsy". Percutaneous nephrolithotomy (PNL), in conjunction with intracorporeal lithotripsy, allows for the rapid removal of any kidney stone regardless of size. Currently, the choice of intracorporeal lithotripters includes ultrasonic, pneumatic, and combined ultrasonic/pneumatic energy sources. Recently, a...
What is the current status of trial NCT00351351?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2006-07. Estimated completion is 2008-05.
What conditions does trial NCT00351351 study?
This clinical trial studies the following conditions: Kidney Stones.
What interventions are being tested in trial NCT00351351?
The interventions under investigation include: Cyberwand (DEVICE), single probe ultrasonic (DEVICE).
Who is sponsoring clinical trial NCT00351351?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00351351 being conducted?
This trial has 7 study locations across Illinois, Indiana, Maryland, North Carolina, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stones
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00351351's enrollment target sits among peer trials
70 8th of 15 higher than 8 of 15 other Kidney Stones trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stones trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Evaluation of Eye Gaze Sharing in the Operating Room
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Eye Gaze Guidance Evaluation in Phantoms
RECRUITING · NA
-
Oxalate-Driven Host Responses in Kidney Stone Disease
RECRUITING · NA
-
Ultrasound Imaging of Kidney Stones and Lithotripsy
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia